Margaret M. Redfield

Mar 25, 2024 | jamanetwork.com | Daniel Davies |Margaret M. Redfield |Christopher Scott

Key PointsQuestion  Which patients with heart failure and preserved ejection fraction (HFpEF) have an increased risk of transthyretin amyloid cardiomyopathy (ATTR-CM) warranting technetium Tc 99m pyrophosphate scintigraphy?

Jun 1, 2023 | jacc.org | Akshay S. Desai |Carolyn S.P. Lam |John McMurray |Margaret M. Redfield

JACC Journals › JACC: Heart Failure › Archives › Vol. 11 No. 6 AbstractAlthough patients with heart failure with preserved ejection fraction (HFpEF) (left ventricular ejection fraction ≥50%) comprise nearly half of those with chronic heart failure, evidence-based treatment options for this population have historically been limited.

Mar 14, 2023 | jamanetwork.com | Margaret M. Redfield |Barry A. Borlaug

Preliminary Communication Atrial Pacing for Chronotropic Incompetence in HFpEF Yogesh N. V. Reddy, MBBS, MSc; Katlyn E. Koepp, PhD; Rickey Carter, PhD; Sithu Win, MD; Christopher Charles Jain, MD; Thomas P. Olson, PhD; Bruce D. Johnson, PhD; Robert Rea, MD; Margaret M. Redfield, MD; Barry A. Borlaug, MD Remote Cardiac Monitoring in Patients With Heart Failure Peter J. Kennel, MD; Hannah Rosenblum, MD; Kelly M.